Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Silvia Pirondi"'
Autor:
Chiara Marraccini, Gaetano Marverti, Glauco Ponterini, Franca Esposito, Domenico D'Arca, Michela Pela, Maria Rosaria Amoroso, Andrea Martello, Maria Paola Costi, Filippo Genovese, Paul Perco, Remo Guerrini, Alessandra Gualandi, Silvia Pirondi, Laura Taddia
Publikováno v:
Journal of proteome research. 13(11)
The preclinical study of the mechanism of action of anticancer small molecules is challenging due to the complexity of cancer biology and the fragmentary nature of available data. With the aim of identifying a protein subset characterizing the cellul
Autor:
Filippo Genovese, Alessandra Gualandi, Laura Taddia, Gaetano Marverti, Silvia Pirondi, Chiara Marraccini, Paul Perco, Michela Pelà, Remo Guerrini, Maria Rosaria Amoroso, Franca Esposito, Andrea Martello, Glauco Ponterini, Domenico D’Arca, Maria Paola Costi
Publikováno v:
Journal of proteome research. 15(10)
Autor:
Michela Pela, Gaetano Marverti, Maria Paola Costi, Filippo Genovese, Chiara Marraccini, Andrea Martello, Glauco Ponterini, Silvia Pirondi, Domenico D'Arca, Puneet Saxena, Stefania Ferrari, Remo Guerrini, Rosaria Luciani, Severo Salvadori, Matteo Santucci
Publikováno v:
Journal of medicinal chemistry. 57(4)
Thymidylate synthase (TS) is a target for pemetrexed and the prodrug 5-fluorouracil (5-FU) that inhibit the protein by binding at its active site. Prolonged administration of these drugs causes TS overexpression, leading to drug resistance. The pepti
Autor:
Silvia Pirondi, Remo Guerrini, Stefania Ferrari, Chiara Marraccini, Giuseppe Cannazza, Gaetano Marverti, Michela Pela, Maria Paola Costi, Giorgia Pavesi, Addolorata Stefania Cazzato, Chiara Frassineti, Glauco Ponterini
Information on the cellular internalization and stability of the ovarian cancer cell growth inhibitor peptide, LSCQLYQR (LR), is vital for lead optimization. Ad-hoc-synthesized LR/fluorescent-probe conjugates were used to monitor the internalization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b7a9010f2ef6fe0f76ee026e94570dc
http://pubs.acs.org/jmc
http://pubs.acs.org/jmc
Autor:
Pela', Michela, Trapella, Claudio, Guerrini, Remo, Gaetano, Marverti, Silvia, Pirondi, Chiara, Marraccini, Severo, Salvadori, Maria Paola Costi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3709::8556a333aa63cf373492a45983e20c12
http://hdl.handle.net/11392/2295822
http://hdl.handle.net/11392/2295822
Autor:
Pela', Michela, Trapella, Claudio, Guerrini, Remo, Salvadori, Severo, Gaetano, Marverti, Silvia, Pirondi, Rosaria, Luciani, Maria Paola Costi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3709::03ce77d5c42ef6f3a76d8dceba1eadc7
http://hdl.handle.net/11392/2295819
http://hdl.handle.net/11392/2295819
Autor:
Maria Paola Costi, Alberto Venturelli, Cristina Magnoni, Paola Azzoni, Daria Morini, Silvia Pirondi, Stefania Seidenari, Stefania Giudice, Eugenia Veratti, Giorgia Bertazzoni, Luisa Benassi
Melanoma is one of the most common cancers, and its incidence has continued to increase over the past few decades. Chemotherapy resistance and related defects in apoptotic signaling are critical for the high mortality of melanoma. Effective drugs are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa239739eb12d4d69cb855a21221c4e1
https://hdl.handle.net/11380/708554
https://hdl.handle.net/11380/708554
Autor:
Giudice, Stefania, Benassi, Luisa, Bertazzoni, Giorgia, Veratti, Eugenia, Morini, Daria, Azzoni, Paola, Costi, Maria, Venturelli, Alberto, Pirondi, Silvia, Seidenari, Stefania, Magnoni, Cristina
Publikováno v:
Investigational New Drugs; Aug2012, Vol. 30 Issue 4, p1484-1492, 9p